由磺酰脲受体 1 突变引起的新生儿糖尿病:ATP 敏感性钾通道表达和 Mg-核苷酸门控缺陷之间的相互作用。

Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.

机构信息

Department of Biochemistry and Molecular Biology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97239, USA.

出版信息

J Clin Endocrinol Metab. 2010 Dec;95(12):E473-8. doi: 10.1210/jc.2010-1231. Epub 2010 Sep 1.

Abstract

CONTEXT

ATP-sensitive potassium (KATP) channels regulate insulin secretion by coupling glucose metabolism to β-cell membrane potential. Gain-of-function mutations in the sulfonylurea receptor 1 (SUR1) or Kir6.2 channel subunit underlie neonatal diabetes.

OBJECTIVE

The objective of the study was to determine the mechanisms by which two SUR1 mutations, E208K and V324M, associated with transient neonatal diabetes affect KATP channel function.

DESIGN

E208K or V324M mutant SUR1 was coexpressed with Kir6.2 in COS cells, and expression and gating properties of the resulting channels were assessed biochemically and electrophysiologically.

RESULTS

Both E208K and V324M augment channel response to MgADP stimulation without altering sensitivity to ATP4- or sulfonylureas. Surprisingly, whereas E208K causes only a small increase in MgADP response consistent with the mild transient diabetes phenotype, V324M causes a severe activating gating defect. Unlike E208K, V324M also impairs channel expression at the cell surface, which is expected to dampen its functional impact on β-cells. When either mutation was combined with a mutation in the second nucleotide binding domain of SUR1 previously shown to abolish Mg-nucleotide response, the activating effect of E208K and V324M was also abolished. Moreover, combination of E208K and V324M results in channels with Mg-nucleotide sensitivity greater than that seen in individual mutations alone.

CONCLUSION

The results demonstrate that E208K and V324M, located in distinct domains of SUR1, enhance transduction of Mg-nucleotide stimulation from the SUR1 nucleotide binding folds to Kir6.2. Furthermore, they suggest that diabetes severity is determined by interplay between effects of a mutation on channel expression and channel gating.

摘要

背景

三磷酸腺苷敏感性钾 (KATP) 通道通过将葡萄糖代谢与β细胞膜电位偶联来调节胰岛素分泌。磺酰脲受体 1 (SUR1) 或 Kir6.2 通道亚基的功能获得性突变是新生儿糖尿病的基础。

目的

本研究的目的是确定与短暂性新生儿糖尿病相关的两种 SUR1 突变(E208K 和 V324M)影响 KATP 通道功能的机制。

设计

将 E208K 或 V324M 突变 SUR1 与 Kir6.2 在 COS 细胞中共表达,并通过生化和电生理方法评估由此产生的通道的表达和门控特性。

结果

E208K 和 V324M 均增强了通道对 MgADP 刺激的反应,而不改变对 ATP4-或磺酰脲类药物的敏感性。令人惊讶的是,虽然 E208K 仅导致 MgADP 反应的微小增加,与轻度短暂性糖尿病表型一致,但 V324M 导致严重的激活门控缺陷。与 E208K 不同,V324M 还会损害细胞表面的通道表达,这预计会减弱其对β细胞的功能影响。当任何一种突变与先前显示可消除 Mg-核苷酸反应的 SUR1 第二核苷酸结合域的突变结合时,E208K 和 V324M 的激活作用也被消除。此外,E208K 和 V324M 的组合导致 Mg-核苷酸敏感性大于单独突变的 Mg-核苷酸敏感性。

结论

结果表明,E208K 和 V324M 位于 SUR1 的不同结构域,增强了从 SUR1 核苷酸结合折叠到 Kir6.2 的 Mg-核苷酸刺激的转导。此外,它们表明糖尿病的严重程度取决于突变对通道表达和通道门控的影响之间的相互作用。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索